Clinical Trial Update: A Study of Xolair to Evaluate Effectiveness and Long-Term Safety in Patients With Moderate to Severe Asthma

View source ↗

Summary

This trial update reports the completion of a long-term safety and effectiveness study of Xolair (omalizumab) in patients with moderate to severe asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Xolair (omalizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Asthma | Status: COMPLETED